LONDON, UK / ACCESSWIRE / September 8, 2017 / Pro-Trader Daily takes a closer look at Ventas, Inc. (NYSE: VTR) as the Company's stock will begin trading ex-dividend on September 11, 2017. In order to capture the dividend payout, investors must purchase the stock a day prior (excluding weekend) to the ex-dividend date that is by latest at the end of the trading session on September 08, 2017. Are you looking for research on dividend stocks, if so register with us now for your free membership at:

http://protraderdaily.com/register/

Today, PRO-TD covers ex-dividend news on VTR. Get our free coverage by signing up at:

http://protraderdaily.com/optin/?symbol=VTR

Dividend Declared

On August 30, 2017, Ventas has declared a regular quarterly dividend of $0.775 per share, payable in cash on September 29, 2017, to stockholders of record on September 12, 2017. The dividend is the third quarterly installment of the Company's 2017 annual dividend.

Ventas' indicated dividend represents a yield of 4.50%, which is substantially higher compared to the average dividend yield of 3.25% for the Financial sector. The Company has raised its dividend for six consecutive years.

Dividend Insights

Ventas has a dividend payout ratio of 74.3%, which means that the Company distributes approximately $0.74 for every $1.00 earned. The dividend payout ratio reflects how much amount a company is returning to shareholders versus how much money it is keeping on hand to reinvest in growth, to pay off debt, and/or to add to its cash reserves.

According to analysts' estimates, Ventas is forecasted to report earnings of $1.89 for the next year compared to its annualized dividend of $3.10. Ventas is a Real Estate Investment Trust (REIT) which are structured by law to distribute at least 90% of earnings. Moreover, since REITs generate income from owning portfolios of investment real estate, they are likely to have higher depreciation charges.

Since depreciation is a non-cash charge, it does not directly impact the ability of dividend the Companies can distribute. For this reason, Fund from Operations (FFO) is calculated by adding depreciation and amortization to earnings, subtracting any gains on sales which provide a better picture of any REIT's profitability and capacity to pay and sustain dividends. For instance, for the quarter ended June 30, 2017, Ventas' income from continuing operations per diluted common share grew 5% to $0.42 on a y-o-y basis. The Company's reported FFO per diluted common share defined by the National Association of Real Estate Investment Trusts ("NAREIT FFO") totaled $1.04 which should sufficiently cover the dividend payout.

Ventas' net cash provided by operating activities was $737.26 million for Q2 2017 compared to operating cash flows of $660.74 million for the year ago same period. As of June 30, 2017, the Company's cash and cash equivalents totaled $103.35 million compared to $91.28 million at March 31, 2017. The Company's strong financial position indicates its ability to absorb any fluctuations in earnings and cash flow and to sustain its dividend distribution for a long period.

Recent Development for Ventas

On August 31, 2017, Ventas announced that it has completed the first phase of its pending sale of 36 owned skilled nursing facilities (Ventas SNFs) that are currently operated by Kindred Healthcare, Inc. to facilitate Kindred's exit from its skilled nursing facility ("SNF") business. Upon the completion of Kindred's SNF sale to an affiliate of BlueMountain Capital Management LLC, Ventas received its allocable portion of proceeds for the 22 Ventas SNFs sold in this phase for a total purchase price of $488 million which represents a 7% cash yield on rent for these assets.

Ventas continues to expect to receive aggregate proceeds of $700 million for the sale of the 36 Ventas SNFs by year end 2017, inclusive of the completed sale. This total anticipated sale price represents a seven percent cash yield on current annual cash rent of $50 million and an eight percent GAAP yield. Ventas is expected to record a gain exceeding $600 million for the sale of the 36 Ventas SNFs.

About Ventas

Ventas, Inc., an S&P 500 Company, is a leading REIT. Its diverse portfolio of approximately 1,300 assets in the US, Canada, and the United Kingdom consists of seniors housing communities, medical office buildings, life science, and innovation centers, inpatient rehabilitation and long-term acute care facilities, health systems, and skilled nursing facilities. Through its Lillibridge subsidiary, Ventas provides management, leasing, marketing, facility development, and advisory services to highly rated hospitals and health systems throughout the United States.

Stock Performance

On Thursday, September 07, 2017, the stock closed the trading session at $69.03, slightly rising 0.99% from its previous closing price of $68.35. A total volume of 1.16 million shares have exchanged hands. Ventas' stock price surged 5.45% in the last one month, 3.68% in the past three months, and 14.92% in the previous six months. Furthermore, since the start of the year, shares of the Company have rallied 10.41%. The stock is trading at a PE ratio of 41.26 and has a dividend yield of 4.49%. The stock currently has a market cap of $24.51 billion.

Pro-Trader Daily:

Pro-Trader Daily (Pro-TD) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and Canadian stocks. PRO-TD has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.

PRO-TD has not been compensated; directly or indirectly; for producing or publishing this document.

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the "Author") and is fact checked and reviewed by a third party research service company (the "Reviewer") represented by a credentialed financial analyst [for further information on analyst credentials, please email contact@protraderdaily.com. Rohit Tuli, a CFA® charterholder (the "Sponsor"), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by PRO-TD. PRO-TD is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.

NO WARRANTY

PRO-TD, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. PRO-TD, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, PRO-TD, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither PRO-TD nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://protraderdaily.com/disclaimer/.

CONTACT

For any questions, inquiries, or comments reach out to us directly. If you're a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:

Email: contact@protraderdaily.com

Phone number: (917) 341.4653

Office Address: Mainzer Landstrasse 50 Frankfurt am Main, Germany 60325

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: Pro-Trader Daily